Disorders of Sphingolipid Metabolism
Metabolic
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| venglustat | Sanofi (SNY) |
Frequently asked questions
How many drugs are in development for Disorders of Sphingolipid Metabolism?
BioSniper tracks 1 drug in development for Disorders of Sphingolipid Metabolism across 1 company.
How many clinical trials target Disorders of Sphingolipid Metabolism?
There are 1 clinical trial targeting Disorders of Sphingolipid Metabolism tracked by BioSniper.
Deep-dive into Disorders of Sphingolipid Metabolism
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis